{"preliminary_commentary":{"by_channel":{"x_thread":3},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build."},"free_build":{"available":false},"name":"NCT03541850","nct_id":"NCT03541850","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=nct03541850. The price is an estimate of verified statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":750,"size":"focused","size_rule":"Focused: 1–150 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":"Patients undergo SBRT QOD for 14 days. Patients may also receive ADT comprised of a luteinizing hormone-releasing hormone agonist or a gonadotropin-releasing hormone antagonist, and an oral anti-androgen for 6 months at the discretion of the treating physician.","label":"Treatment (SBRT, ADT)","type":"EXPERIMENTAL"}],"collaborators":["Viewray Inc."],"completion_date":{"date":"2027-11-01","type":"ESTIMATED"},"conditions":["PSA Level Greater Than 0.03","PSA Progression","Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7","Stage II Prostate Adenocarcinoma AJCC v7","Stage III Prostate Adenocarcinoma AJCC v7"],"enrollment":{"count":92,"type":"ACTUAL"},"has_results":false,"interventions":[{"name":"Antiandrogen Therapy","otherNames":["ADT","Androgen Deprivation Therapy","Anti-androgen Therapy","Anti-androgen Treatment","Antiandrogen Treatment","Hormone Deprivation Therapy","Hormone-Deprivation Therapy"],"type":"DRUG"},{"name":"Quality-of-Life Assessment","otherNames":["Quality of Life Assessment"],"type":"OTHER"},{"name":"Stereotactic Body Radiation Therapy","otherNames":["SABR","SBRT","Stereotactic Ablative Body Radiation Therapy"],"type":"RADIATION"}],"last_update":"2025-11-06","lead_sponsor":"Jonsson Comprehensive Cancer Center","official_title":"Prospective Study of Stereotactic Body Radiotherapy (SBRT) Following Radical Prostatectomy","overall_status":"ACTIVE_NOT_RECRUITING","phases":["PHASE2"],"primary_completion_date":{"date":"2026-11-01","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Biochemical recurrence-free survival (BCRFS)","timeFrame":"Up to 5 years"},{"measure":"Physician-scored toxicity","timeFrame":"Up to 5 years"},{"measure":"Patient-reported toxicity outcomes EPIC-26","timeFrame":"Up to 5 years"},{"measure":"Patient-reported toxicity outcomes IPSS","timeFrame":"Up to 5 years"}],"references":[{"citation":"Nikitas J, Ballas LK, Romero T, Lynch C, Ma TM, Valle LF, Sachdeva A, Chong N, Basehart V, Franco A, Reiter R, Saigal C, Chamie K, Litwin MS, Donin NM, Rettig M, Nickols NG, Cao M, Liauw SL, Steinberg ML, Kishan AU. Patient-Reported Outcomes With Stereotactic Intensity Modulated Radiotherapy After Radical Prostatectomy: A Nonrandomized Clinical Trial. JAMA Oncol. 2025 Jul 1;11(7):726-734. doi: 10.1001/jamaoncol.2025.1059.","pmid":"40372727","type":"DERIVED"},{"citation":"Nikitas J, Smith LM, Gao Y, Ma TM, Sachdeva A, Yoon SM, Jiang T, Low DA, Ballas LK, Steinberg ML, Cao M, Kishan AU. The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trial. Radiother Oncol. 2023 Jun;183:109631. doi: 10.1016/j.radonc.2023.109631. Epub 2023 Mar 18.","pmid":"36934894","type":"DERIVED"}],"start_date":{"date":"2019-01-29","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery","url":"https://clinicaltrials.gov/study/NCT03541850"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/nct03541850"}